ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

I HAD A LYMPHOMA/19

Updated on January 7, 2011

GOOD NEWS------ THEN THE DILEMMA

 FIRST THE GOOD NEWS.

Sitting in a deserted waiting room at the end of the day{even the Reception Staff had gone home} certainly increases apprehension when waiting for a Consultant as we found out yesterday. The normally full waiting room was eerily silent as we waited for 30 minutes in splendid isolation, our appointment, last of the day at 4.45 pm..

Eventually came the summons and as usual, we went to a deserted consulting room to await the arrival of Consultant and the news that we, [wife and I} had been hanging on for all day. The young Dr ISLAM, was first to enter with the immediate uplifting news that PET/CT/3 Scan showed, as was hoped for by us, that the Cancer was in FULL REMISSION. That following on from the earlier good news of PET/CT/2 that the Chop Chemo had zapped the Lymphoma was as good as it gets from a patient"s perspective.

Dr Islam then went on to explain that they still wished to adopt a cautious approach and to complete Chop/8 and 2 further Intrathecal Lumbar Puncture. Now had things gone to plan, Intrathecal 3 would have been completed a couple of hours earlier, but my Blood Tests showed me again to be Neutropenic, if only just. As a result the Doctor and I agreed that I would take an early blood test next day and see if CHOP/8 could go ahead as planned.

I can now report that the blood test I had this morning and which I took directly to Pathology has proved ok and the CHOP goes ahead today. Also, the Intrathecal 3 is now set for next Thursday and 2 weeks later the final one on Jan 28. The cooperation from blood tests, pathology, and the reception at the Chemo Centre to facilitate these events has been, as with everything I have received from the NHS Hospital, been absolutely first class and ,as I have recorded before Cold not have received better care, consideration and treatment anywhere, regardless of whether it was Private or not. These people, without fuss or standing on ceremony have all dealt with things in a friendly but nevertheless totally professional manner and I owe them a great deal.

So, Jan 28 sees the completion of treatment---- OR DOES IT?

THE DILEMMA.

Having related the above, Dr Islam, then began to put forward a further aspect, "for your consideration". At this point, enter stage right,  on cue Dr Cervi, Chief Consultant! At once the susceptibilities heighten ,as the good Doctor seems only to appear at pivotal moments. Dr Islam continued to explain that, though I am 70 and the normal cut off age for what they now propose is 65, they felt I would be able to withstand the isolation course of Bone Marrow removal and high dose Chemo that proves, apparently invaluable in blocking a return of the T-Cell Lymphoma which had attacked me and which could possibly return, with treatment problems created in the future if it were so to do.

Dr Cervi then took up the reins and ,as previously advised, told us this would require going to a London Hospital to see a Professor to discuss the treatment in detail, obtain his decision as to my suitability and take physical tests for heart ,lungs,kidneys, liver etc. to ascertain  if they are in suitable condition to withstand the high dose involved. Following this all parties agreed that it was for the best for us to have an appointment arranged with the Professor to discuss matters face to face and in depth prior to any final decision being made or required.

So, the dilemma is really "Stick"  or "Twist !" I must do my own research and have my son already contacting an Oncologist friend for a "second opinion". More to report on in future Hubs, but for the present, the news is good and the prospects ever brightening for the future. I may miss out on Egypt this Spring but Turkey from May 20th. looks very solid and with the current UK weather, that cannot come quickly enough, I can assure you!

 

Comments

    0 of 8192 characters used
    Post Comment

    No comments yet.

    working

    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, hubpages.com uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at: https://hubpages.com/privacy-policy#gdpr

    Show Details
    Necessary
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the googleapis.com or gstatic.com domains, for performance and efficiency reasons. (Privacy Policy)
    Features
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Marketing
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Statistics
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)